PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Steve Yoder on Q2 2020 Results - Earnings Call Transcript
Pieris Pharmaceuticals, Inc. (PIRS)
Q2 2020 Earnings Conference Call
August 10, 2020 08:00 AM ET
Company Participants
Tom Bures - Vice President of Finance
Steve Yoder - President and Chief Executive Officer
Ingmar Bruns - Senior Vice President and Head of Clinical Development
Hitto Kaufmann - Senior Vice President and Chief Scientific Officer
Shane Olwill - Senior Vice President and Head of Translational Science
Conference Call Participants
Jonathan Miller - Evercore ISI
Madhu Kumar - Robert W. Baird & Co.
Biren Amin - Jefferies LLC
Matt Phipps - William Blair & Company
Presentation
Operator
Greetings,